|

Myeloproliferative Neoplastic Diseases Observatory From Brest

RECRUITINGSponsored by University Hospital, Brest
Actively Recruiting
SponsorUniversity Hospital, Brest
Started2015-09-01
Est. completion2025-09-30
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02897297

Summary

All patients diagnosed or followed in Brest University Hospital for Philadelphia negative myeloproliferative neoplasms will be included in this observational study. Myeloproliferative neoplasms recorded included: polycythemia vera, essential Thrombocythemia and Primary Myelofibrosis. This is a not interventional study. Alive patients need to sign a non-opposition consent form. Patients will be followed until last news (death, change of reference centre...).

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients with essentiel thrombocythemia, polycythemia vera or primary myelofibrosis
* Signature of the non-opposition consent form

Exclusion Criteria:

* None

Conditions4

CancerEssential ThrombocythemiaPolycythemia VeraPrimary Myelofibrosis

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.